Testing effectiveness (Phase 2)Study completedNCT00003356What this trial is testingRituximab Plus Interleukin-2 in Treating Patients With LymphomaWho this might be right forLymphoma University of Rochester 58
Testing effectiveness (Phase 2)Ended earlyNCT02488512What this trial is testingPeptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell LymphomasWho this might be right forDLBCLMCLRecurrent Disease Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1
Testing effectiveness (Phase 2)Study completedNCT00088205What this trial is testingOral Enzastaurin in Participants With Relapsed Mantle Cell LymphomaWho this might be right forMantle-Cell Lymphoma Eli Lilly and Company 60
Testing effectiveness (Phase 2)UnknownNCT03185494What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22Who this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578077What this trial is testingGolcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell LymphomaWho this might be right forRecurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma City of Hope Medical Center 58
Testing effectiveness (Phase 2)WithdrawnNCT03617484What this trial is testingBortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma University of Michigan Rogel Cancer Center
Large-scale testing (Phase 3)Study completedNCT00075478What this trial is testingTotal-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionAggressive Non-Hodgkin Lymphoma+10 more Fred Hutchinson Cancer Center 87
Early research (Phase 1)Study completedNCT00621452What this trial is testingGenetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+8 more Fred Hutchinson Cancer Center 12
Early research (Phase 1)WithdrawnNCT00004114What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00004904What this trial is testingStem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01652144What this trial is testingA Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma NCIC Clinical Trials Group 12
Testing effectiveness (Phase 2)Study completedNCT00505232What this trial is testingSafety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)Who this might be right forMantle Cell Lymphoma CABYC 30
Early research (Phase 1)Study completedNCT01300026What this trial is testingAMG 319 Lymphoid Malignancy FIHWho this might be right forCancerChronic Lymphocytic LeukemiaDiffuse Large Cell Lymphoma+11 more Amgen 28
Testing effectiveness (Phase 2)Study completedNCT00086944What this trial is testingOblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02213926What this trial is testingAn Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma (MCL) Acerta Pharma BV 124
Testing effectiveness (Phase 2)Study completedNCT00144092What this trial is testingHDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's LymphomaWho this might be right forLow Grade Lymphoma Alberta Health services 60
Testing effectiveness (Phase 2)Study completedNCT01314014What this trial is testingImexon for Relapsed Follicular and Aggressive LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more University of Rochester 22
Not applicableStudy completedNCT03054883What this trial is testingObservational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose TherapyWho this might be right forMantle Cell Lymphoma Czech Lymphoma Study Group 73
Early research (Phase 1)Study completedNCT00002759What this trial is testingIrinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaWho this might be right forDrug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT02278796What this trial is testingA Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)Who this might be right forLymphoma, Large B-Cell, DiffuseLymphoma, FollicularLymphoma, Mantle-Cell Insel Gruppe AG, University Hospital Bern 108